Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden · Delayed Price · Currency is SEK 14.32
-0.52 (-3.50%)
Mar 2, 2026, 4:17 PM CET
Diamyd Medical AB Market Cap
Diamyd Medical AB has a market cap or net worth of 2.02 billion as of March 2, 2026. Its market cap has increased by 18.24% in one year.
Market Cap
2.02B
Enterprise Value
1.79B
Revenue
349.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
14.32
Market Cap Chart
Since May 20, 2013, Diamyd Medical AB's market cap has increased from 132.51M to 2.02B, an increase of 1,423.23%. That is a compound annual growth rate of 23.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 2.02B | 30.37% |
| Dec 30, 2025 | 1.55B | -9.52% |
| Dec 30, 2024 | 1.71B | 182.47% |
| Dec 29, 2023 | 605.80M | -41.10% |
| Dec 30, 2022 | 1.03B | -9.66% |
| Dec 30, 2021 | 1.14B | -46.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.44B |
| Flerie AB | 2.85B |
| Vicore Pharma Holding AB | 2.83B |
| Saniona AB | 2.57B |
| Egetis Therapeutics AB | 1.81B |
| BioInvent International AB | 1.53B |
| Cantargia AB | 1.18B |
| Genovis AB (publ.) | 1.14B |